$4.97
+0 (+0%)
At Close: Aug 29, 2025
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
11:00am, Saturday, 18'th May 2024
LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or
NEW YORK--(BUSINESS WIRE)-- #Investigation--The law firm of Kirby McInerney LLP reminds investors of the May 28, 2024 deadline to seek the role of lead plaintiff in a federal securities class action t
Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join – Contact Levi & Korsinsky
04:45pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - BLUE
12:30pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Shareholders of bluebird bio, Inc. Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
12:30pm, Friday, 17'th May 2024
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, NY / ACCESSWIRE / May 17, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE
05:45pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
BLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:45pm, Thursday, 16'th May 2024
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
04:45pm, Thursday, 16'th May 2024
LOS ANGELES , May 16, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit again
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
11:00am, Thursday, 16'th May 2024
LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or
Is Bluebird Bio Stock a Buy?
09:22am, Thursday, 16'th May 2024
Bluebird Bio has launched three gene-editing therapies. These treatments are expensive and complex to administer, and they face stiff competition.
Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
03:00pm, Wednesday, 15'th May 2024
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / If you suffered a loss on your bluebird bio, Inc. (NASDAQ:BLUE) investment and want to learn about a potential recovery under the federal securities laws, fo
Sign In
Buy BLUE